During the past couple of weeks, three large companies, AbbVie, Lilly, and Pfizer have recieved requests by the FDA that essentially delay the approval of their atopical dermatitis drugs that function as JAK inhibitors (1). Pfizer has been developing abrocitinib, an oral drug that is a selective JAK inhibitor and is designed for treatment of …
60 million children in the U.S. have been diagnosed with ADHD, accounting to almost 10% of all children (1). Many groups have their theories why ADHD is on an increase in all generations, younger ones included, but an undisputed fact is that attention-deficit disorders are on the rise. The canonical treatment for the disorders are …
FDA Approves Viloxazine: A New ADHD Treatment For Children Read More »
AbbVie has recently come out with updates on applications of Rinvoq, generic name upadacitinib, which has already been approved as a secondary rheumatoid arthritis treatment in 2019. The new updates highlight the potential of the drug as a secondary psoriatic arthritis (PsA) treatment when other approved treatments have proven to be underwhelming.
Bone marrow suppression is a virtually ubiquitous side effect of chemotherapy that limits the dose of the chemo drug. However, a new drug, trilaciclib, can make this a problem of the past. The drug, trade name Cosela, is being developed by G1 Theraputics, and has already been approved for use by the FDA for patients …
The Better Future of Chemotherapy: Myeloprotection Therapy for Small-Cell Lung Cancer Read More »
The Non Steroidal Anti Inflammatory Drug (NSAID) class is present in virtually every household and first aid kit. However, widely-popular drugs like aspirin, ibuprofen, and naproxen have issues concerning their gastrointestinal safety, leading to an increased risk of gastrointestinal ulcers and bleeds. The company Antibe Theraputics are developing a drug derivative of naproxen, called Otenaproxesul, …
The idea of the “magic bullet” that perfectly breaches only target cells and proceeds to kill them, has long been the fantasy of pharmacology. This fantasy is being brought closer to reality every year, and the research on albomycin compounds shows definite progress towards this end goal. And new research shows that there is more …
Albomycins: An unexplored group with potential to be the future of antibiotics? Read More »